All News about Bristol-Myers Squibb
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Via Benzinga
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
Via Benzinga
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Via Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via Benzinga
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
Via Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|